Abstract
Glioblastoma (GBM) developed metastases rarely and the prognosis, in these cases, was very poor. We reported a 30-year patient who, developing intramedullary and leptomeningeal metastases from GBM, underwent palliative spinal radiotherapy (RT) and Bevacizumab.
MeSH terms
-
Adult
-
Angiogenesis Inhibitors / administration & dosage
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Bevacizumab
-
Brain Neoplasms / pathology
-
Brain Neoplasms / surgery
-
Brain Neoplasms / therapy*
-
Chemoradiotherapy / methods*
-
Glioblastoma / secondary
-
Glioblastoma / surgery
-
Glioblastoma / therapy*
-
Humans
-
Male
-
Meningeal Neoplasms / secondary
-
Meningeal Neoplasms / surgery
-
Meningeal Neoplasms / therapy*
-
Spinal Cord Neoplasms / secondary
-
Spinal Cord Neoplasms / surgery
-
Spinal Cord Neoplasms / therapy*
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab